Recent findings have shown that by activating BA-related receptors such as FXR, the synthesis and secretion of BAs can be effectively reduced, and accumulation of BAs in the liver can be reduced, thus minimizing hepatocellular injury and inflammatory response and inhibiting the progression of HCC [97,98]. Here, NR1H4 is linked to hepatocellular carcinoma.